A bill to amend title VIII of the Defense Production Act of 1950 to include biotechnology in the definitions of “prohibited technology” and “notifiable technology”, and for other purposes.

S. 5316 would amend title VIII of the Defense Production Act of 1950 to add biotechnology to the categories of "prohibited technology" and "notifiable technology" under that law. Title VIII establishes a framework for reviewing and restricting certain technology transactions on national security grounds; this bill would extend that framework to cover biotechnology specifically. Beyond this stated purpose, the bill's full text has not yet been published, so the specific definitions, scope, and mechanisms it would use are not yet known.

Because the details are not available, it is not yet possible to say precisely which companies, transactions, or activities would be affected, or how. In general terms, provisions like this typically affect entities involved in transactions or technology transfers subject to Defense Production Act review, but until the text is released, any specific effects should not be assumed.

The bill was introduced in the U.S. Senate on August 6, 2026, by Senator Pete Ricketts (R-NE). Its only recorded action so far is introduction. From here, it would typically be referred to a Senate committee for review; whether it advances further — through committee consideration, floor votes, and potentially the House — depends on future action that has not yet occurred. Full details of the bill's provisions should become available once its text is published.

Plain-English summary generated by Bill100 AI from the official record. Always verify against the source below.